T
Taiichi Shiotani
Researcher at Indiana University
Publications - 8
Citations - 165
Taiichi Shiotani is an academic researcher from Indiana University. The author has contributed to research in topics: Neoplastic transformation & Pyrimidine metabolism. The author has an hindex of 6, co-authored 8 publications receiving 163 citations.
Papers
More filters
Journal ArticleDOI
Biochemical strategy of the genome as expressed in regulation of pyrimidine metabolism
George Weber,Taiichi Shiotani,Harutoshi Kizaki,Diana Tzeng,James C. Williams,Norma Gladstone +5 more
TL;DR: The biochemical strategy of the mammalian genome was examined as expressed in thymidine metabolism and in uridylate and CTP biosynthesis under experimental conditions where the increased replicative process required an integrated modulation of gene expression, such as in regeneration, differentiation, and in neoplastic transformation and progression.
Journal ArticleDOI
Colon tumor: Enzymology of the neoplastic program
TL;DR: The striking increases in the activities of CTP synthetase, OMP decarboxylase, glutamine PRPP amidotransferase and thymidine kinase mark out these enzymes as potentially sensitive targets for combination chemotherapy by specific inhibitors of these enzyme activities.
Journal ArticleDOI
Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
Shuji Matsubara,Y Yamaji,Toshikazu Fujita,Toshiya Kanayama,Ichiro Yamadori,Makoto Sato,Jiro Fujita,Taiichi Shiotani,Jiro Takahara +8 more
TL;DR: The presence of recoverin or recoverin-like immunoreactivity in SCLC with CAR syndrome supports the hypothesis that the cancer-retina immunologic cross-reaction contributes to visual loss in this syndrome.
Book ChapterDOI
The Molecular Correlation Concept of Neoplasia: Recent Advances and New Challenges
TL;DR: This paper critically evaluates the advances made with the molecular correlation concept as a conceptual and experimental approach in elucidating the biochemical strategy of the cancer cells.
Journal ArticleDOI
Biochemical strategy of hepatomas.
TL;DR: With the recognition of the ordered pattern of reprogramming of gene expression in hepatomas, the path is open for the development of sensitive assays for biochemical diagnosis of liver tumors and for a rational design of selective chemotherapy and rescue.